* NextGen Healthcare Inc NXGN.OQ NXGN.O is expected to show
a rise in quarterly revenue when it reports results on October
28.
* The Atlanta, Georgia-based company is expected to report a
2.4% increase in revenue to $143.385 million from $140 million a
year ago, according to the mean estimate from 7 analysts, based
on Refinitiv data.
* Refinitiv's mean analyst estimate for NextGen Healthcare Inc
is for earnings of 23 cents per share. For the same quarter last
year, the company reported earnings of 30 cents per share.
* The current average analyst rating on the shares is "hold" and
the breakdown of recommendations is 2 "strong buy" or "buy," 4
"hold" and 1 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the
last three months.
* Wall Street's median 12-month price target for NextGen
Healthcare Inc is $22, about 32% above its last closing price
of $14.97.
* Previous quarterly performance (using preferred earnings
measure in US dollars).
QUARTER STARMINE REFINITIV ACTUAL BEAT, SURPRI
ENDING SMARTESTIM IBES MET, SE %
ATE® ESTIMATE MISSED
Jun. 30 2021 0.21 0.21 0.25 Beat 20.3
Mar. 31 2021 0.19 0.19 0.21 Beat 8.8
Dec. 31 2020 0.24 0.25 0.26 Beat 5.4
Sep. 30 2020 0.20 0.20 0.30 Beat 48.5
Jun. 0.08 0.08 0.21 Beat 152
30 2020
Mar. 31 2020 0.19 0.19 0.20 Beat 3
Dec. 31 2019 0.20 0.20 0.23 Beat 15.2
Sep. 30 2019 0.23 0.23 0.24 Beat 4.5
This summary was machine generated October 27 at 10:13 GMT. All
figures in US dollars unless otherwise stated